11/18
05:41 pm
caba
Cabaletta Bio, Inc. (NASDAQ: CABA) had its "outperform" rating re-affirmed by analysts at William Blair.
Medium
Report
Cabaletta Bio, Inc. (NASDAQ: CABA) had its "outperform" rating re-affirmed by analysts at William Blair.
11/18
05:41 pm
caba
Cabaletta Bio, Inc. (NASDAQ: CABA) had its "outperform" rating re-affirmed by analysts at William Blair.
Medium
Report
Cabaletta Bio, Inc. (NASDAQ: CABA) had its "outperform" rating re-affirmed by analysts at William Blair.
11/15
02:12 pm
caba
Rating for CABA
Low
Report
Rating for CABA
11/15
02:12 pm
caba
Rating for CABA
Low
Report
Rating for CABA
11/15
08:03 am
caba
Cabaletta Bio, Inc. (NASDAQ: CABA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $25.00 price target on the stock.
High
Report
Cabaletta Bio, Inc. (NASDAQ: CABA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $25.00 price target on the stock.
10/10
09:27 am
caba
Rating for CABA
Medium
Report
Rating for CABA
10/10
07:32 am
caba
Cabaletta Bio, Inc. (NASDAQ: CABA) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $10.00 price target on the stock.
Medium
Report
Cabaletta Bio, Inc. (NASDAQ: CABA) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $10.00 price target on the stock.
9/17
08:02 am
caba
Cabaletta Bio, Inc. (NASDAQ: CABA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $25.00 price target on the stock.
Medium
Report
Cabaletta Bio, Inc. (NASDAQ: CABA) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $25.00 price target on the stock.